Page last updated: 2024-09-03

h-d-phe-pip-arg-pna and dermatan sulfate

h-d-phe-pip-arg-pna has been researched along with dermatan sulfate in 5 studies

Compound Research Comparison

Studies (h-d-phe-pip-arg-pna)	Trials (h-d-phe-pip-arg-pna)	Recent Studies (post-2010) (h-d-phe-pip-arg-pna)	Studies (dermatan sulfate)	Trials (dermatan sulfate)	Recent Studies (post-2010) (dermatan sulfate)
95	1	5	2,557	100	394

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (40.00)	18.7374
1990's	3 (60.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asai, K; Asai, M; Ohtsubo, M; Takagi, A	1
Beunis, M; Hemker, HC; van de Ruit, M; van Putten, J	1
Elikowski, W; Grzywacz, A; Przybyl, L; Turowiecka, Z; Vinazzer, H; Zawilska, K; Zozulinska, M	1
Harenberg, J; Malsch, R	1
Hemker, HC; Hendrix, HH; Kolde, HJ; Wagenvoord, RJ	1

Trials

1 trial(s) available for h-d-phe-pip-arg-pna and dermatan sulfate

Article	Year
On the action of a heparan-like glycosaminoglycan (Hemovasal) on the mechanism of haemostasis and fibrinolysis. Thrombosis research, 1995, May-01, Volume: 78, Issue:3 Topics: Administration, Oral; Adult; Anticoagulants; Antithrombin III; Circadian Rhythm; Convalescence; Dermatan Sulfate; Dipeptides; Fibrinolysis; Fibrinolytic Agents; Glycosaminoglycans; Hemostasis; Heparin; Heparin Cofactor II; Humans; Injections, Intramuscular; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Plasminogen Activator Inhibitor 1; Recurrence; Thrombin; Tissue Plasminogen Activator	1995

Article

Year

On the action of a heparan-like glycosaminoglycan (Hemovasal) on the mechanism of haemostasis and fibrinolysis.

Thrombosis research, 1995, May-01, Volume: 78, Issue:3

Topics: Administration, Oral; Adult; Anticoagulants; Antithrombin III; Circadian Rhythm; Convalescence; Dermatan Sulfate; Dipeptides; Fibrinolysis; Fibrinolytic Agents; Glycosaminoglycans; Hemostasis; Heparin; Heparin Cofactor II; Humans; Injections, Intramuscular; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Plasminogen Activator Inhibitor 1; Recurrence; Thrombin; Tissue Plasminogen Activator

1995

Other Studies

4 other study(ies) available for h-d-phe-pip-arg-pna and dermatan sulfate

Article	Year
[Studies on the determination of heparin cofactor II (HC II) activity using a synthetic chromogenic substrate]. Rinsho byori. The Japanese journal of clinical pathology, 1987, Volume: 35, Issue:5 Topics: Adult; Colorimetry; Dermatan Sulfate; Dipeptides; Female; Glycoproteins; Heparin Cofactor II; Humans; Liver Diseases; Male; Reference Values	1987
Determination of low molecular weight heparin in clinical laboratory. Haemostasis, 1984, Volume: 14, Issue:2 Topics: Chondroitin Sulfates; Dermatan Sulfate; Dipeptides; Glycosaminoglycans; Heparin; Heparinoids; Heparitin Sulfate; Humans; Molecular Weight; Oligopeptides; Partial Thromboplastin Time; Reference Values; Spectrophotometry	1984
High-performance size exclusion chromatography and polyacrylamide gel electrophoresis for characterization of unfractionated and low molecular mass glycosaminoglycans. Seminars in thrombosis and hemostasis, 1994, Volume: 20, Issue:2 Topics: Animals; Carbohydrate Sequence; Cattle; Chromatography, Gel; Dermatan Sulfate; Dipeptides; Electrophoresis, Polyacrylamide Gel; Glycosaminoglycans; Heparin, Low-Molecular-Weight; Molecular Sequence Data; Molecular Weight; Oligopeptides; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet	1994
Development of a rapid and sensitive chromogenic heparin assay for clinical use. Haemostasis, 1993, Volume: 23, Issue:1 Topics: Anticoagulants; Antithrombin III; Blood Coagulation Factors; Calcium Chloride; Calibration; Chromogenic Compounds; Dermatan Sulfate; Dextran Sulfate; Dipeptides; Drug Stability; Factor IXa; Heparin; Humans; Oligopeptides; Phospholipids; Platelet Factor 4; Sensitivity and Specificity	1993